Company Performance: Horizon Therapeutics' financial health, including revenue, profitability, and earnings reports, greatly influences investor confidence and the stock price.

Pharmaceutical Pipeline: Progress in developing and launching new drugs, as well as clinical trial results, can significantly impact market sentiment and HRZ.DU's valuation.

Market Conditions: Broader economic factors like interest rates, inflation, and overall market volatility can affect investor appetite for stocks, including Horizon Therapeutics'.

Regulatory Landscape: Government policies, drug pricing regulations, and FDA approvals/rejections play a critical role in the pharmaceutical industry and HRZ.DU's stock performance.

Competition: The competitive environment, including the presence of other pharmaceutical companies and the availability of alternative treatments, can impact Horizon Therapeutics' market share and profitability.

Mergers and Acquisitions: News and rumors regarding potential mergers, acquisitions, or partnerships involving Horizon Therapeutics can cause significant fluctuations in its stock price.

Investor Sentiment: Public perception, media coverage, and analyst ratings can influence investor behavior and the demand for HRZ.DU shares.